两种软件在肝硬化患者腹部CT横断面身体成分分析中的评估
从两个中心随机选取50例肝硬化患者,两名观察者独立使用SliceOmatic V.5.0与Synapse 3D评估腹部CT的肌肉面积、骨骼肌指数、肌肉衰减、内脏脂肪面积/指数及皮下脂肪面积/指数;观察者间与软件间ICC为0.984-0.999(P<0.001),Pearson相关系数0.970-0.998,提示两种软件测量一致性极好。
要点
- 肝硬化患者腹部CT身体成分分析中,SliceOmatic与Synapse 3D测量肌肉和脂肪指标的一致性极好(ICC 0.984-0.999)。
- 观察者间与软件间Pearson相关系数达0.970-0.998,支持两种软件互换用于横断面身体成分评估。
- 评估指标包括CSMA、SMI、MA、VAT、VATI、SAT及SATI。
核心结论
- 使用不同软件程序评估肝硬化患者身体成分时,肌肉量和脂肪库测量均显示极好的一致性。
研究设计与样本
- 从两个中心随机选取50例肝硬化患者,两名观察者独立评估其腹部CT,使用SliceOmatic©V.5.0(Magog,加拿大)和Synapse 3D(Fujifilm)分析CSMA、SMI、MA、VAT、VATI、SAT及SATI。
诊断标准与关键数值
- 观察者间和软件间组内相关系数(ICC)对CSMA、SMI、MA、VAT、VATI、SAT及SATI均高度等效(范围0.984-0.999,P<0.001);所有比较的Pearson相关系数极好(范围0.970-0.998)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The impact of body composition abnormalities and clinical outcomes in patients with cirrhosis is well established. Abdominal computed tomography (CT) evaluation is the technique that is better evaluated; however, agreements are not well known. Fifty patients were randomly selected from two centers, and two observers independently evaluated their CT. The cross-sectional muscle area (CSMA), skeletal muscle index (SMI), muscle attenuation (MA), visceral adipose tissue area (VAT), visceral adipose tissue index (VATI), subcutaneous adipose tissue area (SAT), and subcutaneous adipose tissue area (SATI) were analyzed using SliceOmatic©V.5.0 (Magog, Canada), and Synapse 3D, Fujifilm. The interobserver and intersoftware intra-class correlation coefficients (ICCs) were highly equivalent for CSMA, SMI, MA, VAT, VATI, SAT, and SATI (Range 0.984-0.999, P < 0.001), and excellent Pearson's correlation coefficients were found for all comparisons (Range 0.970-0.998). Using different software programs to evaluate body composition in patients with cirrhosis showed excellent agreement for measuring muscle mass and adipose depots.
引用
- D'Arcangelo F, Zanetto A, Dunichand-Hoedl A, et al. Evaluation of two software programs for cross-sectional body composition analysis on abdominal computed tomography scans of patients with cirrhosis. Eur J Radiol. 2025. PMID: 41518714. doi:10.1016/j.ejrad.2025.112637
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。